Masters Capital Management LLC lessened its stake in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 3.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 3,875,000 shares of the medical instruments supplier’s stock after selling 125,000 shares during the period. Masters Capital Management LLC’s holdings in Transenterix were worth $7,479,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. BlackRock Inc. raised its stake in Transenterix by 157.3% during the 4th quarter. BlackRock Inc. now owns 1,760,266 shares of the medical instruments supplier’s stock valued at $3,397,000 after purchasing an additional 1,076,133 shares during the period. EAM Investors LLC acquired a new stake in Transenterix during the 4th quarter valued at $1,333,000. Raymond James Financial Services Advisors Inc. acquired a new stake in Transenterix during the 4th quarter valued at $113,000. Bank of New York Mellon Corp raised its stake in Transenterix by 94.0% during the 4th quarter. Bank of New York Mellon Corp now owns 119,584 shares of the medical instruments supplier’s stock valued at $231,000 after purchasing an additional 57,944 shares during the period. Finally, Virtu Financial LLC acquired a new stake in Transenterix during the 4th quarter valued at $109,000.
Transenterix Inc (NYSEAMERICAN TRXC) opened at $1.74 on Monday. Transenterix Inc has a one year low of $0.45 and a one year high of $5.00. The firm has a market cap of $344.70, a price-to-earnings ratio of -1.96 and a beta of 2.12.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3257868/masters-capital-management-llc-sells-125000-shares-of-transenterix-inc-trxc.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Want to see what other hedge funds are holding TRXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transenterix Inc (NYSEAMERICAN:TRXC).
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.